GSA CAPITAL PARTNERS LLP - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 241 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,325
+18.0%
216,782
+23.3%
0.13%
-5.8%
Q4 2022$1,123
-99.9%
175,793
+117.6%
0.14%
+35.0%
Q3 2022$774,000
-60.8%
80,776
-54.8%
0.10%
-65.2%
Q2 2022$1,972,000
+604.3%
178,578
+961.5%
0.30%
+678.9%
Q1 2022$280,000
-4.8%
16,823
+9.3%
0.04%
+2.7%
Q4 2021$294,000
+19.0%
15,398
+189.4%
0.04%
-7.5%
Q4 2020$247,000
+81.6%
5,321
-62.7%
0.04%
+185.7%
Q1 2019$136,000
-43.1%
14,266
-47.2%
0.01%
-50.0%
Q4 2018$239,00027,0000.03%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 565,890$26,257,0009.39%
Consonance Capital Management LP 1,710,803$79,381,0007.41%
GREAT POINT PARTNERS LLC 917,427$42,569,0006.91%
Avoro Capital Advisors LLC 7,500,000$348,000,0005.99%
Ghost Tree Capital, LLC 500,000$23,200,0005.17%
FRAZIER MANAGEMENT LLC 1,312,999$60,923,0004.69%
Perceptive Advisors 9,166,304$425,316,0004.56%
Ally Bridge Group (NY) LLC 360,000$16,704,0002.86%
Orbimed Advisors 6,645,100$308,333,0002.70%
ACUTA CAPITAL PARTNERS, LLC 164,800$7,647,0002.08%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders